ArticleJournal of experimental orthopaedics2026
Excellent survivorship and functional outcomes following lateral unicompartmental knee arthroplasty in patients aged 55 years or younger.
Article in Journal of experimental orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Fixed-bearing lateral unicompartmental knee arthroplasty (UKA) is a bone- and ligament-preserving treatment option for isolated lateral-compartment osteoarthritis (OA), but evidence in younger patients remains limited. The primary purpose of this study was to assess lateral component revision-free survival and reoperation-free survival following primary fixed-bearing lateral UKA in patients aged 55 years or younger. Secondary objectives were to evaluate functional and radiological outcomes. Methods: This retrospective case series was derived from a prospectively maintained institutional database. A consecutive series of 84 primary fixed-bearing lateral UKAs in 80 patients aged ≤55 years, performed between January 2016 and December 2021 with a minimum follow-up of 2 years was identified (mean follow-up, 5.3 ± 1.9 years [range, 2.2-8.6 years]; mean age, 51 years [range, 37-55 years]). Kaplan-Meier analysis estimated 5-year survival for lateral component revision or reoperation. Lateral component revision was defined as the removal or exchange of any fixed implant component (femoral or tibial). Reoperation was defined as any subsequent surgical procedure on the operated knee. Functional outcomes were evaluated using the Oxford Knee Score (OKS) and University of California, Los Angeles Activity Score. Radiographic assessment included measurement of the hip-knee-ankle angle (HKAA). Results: Lateral component revision-free survival was 100%, while cumulative reoperation-free survivorship was 92.5% (95% CI: 86.8-98.2) at 5 years. Seven reoperations were observed: 4 additional medial UKAs, 2 arthroscopic procedures and 1 successful debridement, antibiotics and implant retention (DAIR). Mean HKAA changed from 4.8° ± 4.7° valgus preoperatively to 2.0° ± 2.8° valgus postoperatively. Postoperative HKAA demonstrated higher residual valgus in knees without medial-compartment OA progression or osteonecrosis (ON) compared to four knees with medial-compartment OA or ON (2.2° valgus vs. 1.5° varus, Conclusions: Fixed-bearing lateral UKA in younger patients was associated with 100% lateral component revision-free survival and high functional scores at a mean follow-up of 5 years. No implant-related failures, such as aseptic loosening, were observed in this active cohort, although seven knees underwent reoperation, including four additional medial UKAs. Progression of OA in the medial compartment was the most common reason for reoperation. The observed association between postoperative varus alignment and medial-compartment OA progression or ON is limited by the small number of events and requires further investigation. Level of Evidence: Level IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.